[Therapeutic effects of vancomycin, teicoplanin, and ceftizoxime alone and in combination against murine systemic infection in mice caused by "beta-lactam antibiotic induced vancomycin-resistant MRSA"].
Hanaki
Hideaki
H
Infection Scietific Control Research Center, Kitasato Institute, Division of Infectious Disease, Graduate School of Infection Control Sciences, Kitasato University.
Hatano
Kazuo
K
Yokota
Yoshiko
Y
Sunagawa
Keisuke
K
D000818:Animals; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D016106:Methicillin Resistance; D051379:Mice; D008813:Mice, Inbred ICR; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*; D017334:Teicoplanin / Q000008:administration & dosage*; D014640:Vancomycin / Q000008:administration & dosage* / Q000494:pharmacology*; D020713:Vancomycin Resistance; D047090:beta-Lactams / Q000494:pharmacology*
D047090:beta-Lactams; D017334:Teicoplanin; D014640:Vancomycin